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 
Abstract— The major difficulty in the design of closed-loop 
control during anaesthesia is the inherent patient variability 
due to differences in demographic and drug tolerance. These 
discrepancies are translated into the pharmacokinetics (PK), 
and pharmacodynamics (PD). These uncertainties may affect 
the stability of the closed loop control system. This paper aims 
at developing predictive controllers using Internal Model 
Control technique. This study develops patient dose-response 
models and to provide an adequate drug administration 
regimen for the anaesthesia to avoid under or over dosing of 
the patients. The controllers are designed to compensate for 
patients inherent drug response variability, to achieve the best 
output disturbance rejection, and to maintain optimal set point 
response. The results are evaluated compared with traditional 
PID controller and the performance is confirmed in our 
simulation. 
 
I. INTRODUCTION 
NAESTHESIA comprises muscle relaxation, analgesia      
and unconsciousness, Depth of Anaesthesia (DoA), 
and can be defined as the lack of response and recall to 
noxious stimuli. The anaesthetic management of a surgical 
patient is a process that relies on the experience of an 
anaesthetist, since currently there are no direct means of 
assessing a patient level of consciousness during surgery. 
The decision for the initial anaesthetic level is generally 
made by using the recommended drug dosages based on 
different patient characteristics, such as age and weight. The 
anaesthetist determines any subsequent alteration in the 
anaesthetic level by observing physical signs from the 
patient [1]. These physical signs, the indirect indicators of 
the depth of anaesthesia, may include changes in blood 
pressures or heart rate, lacrimation (the production of tears in 
the eyes), facial grimacing, muscular movements, 
spontaneous breathing, diaphoresis (sweating, especially 
sweating induced for medical reasons), and other signs that 
may predicate awareness [2]. However, they are not reliable 
indicators of changes in patient level of consciousness. 
Although an anaesthesiologist can adjust recommended 
anaesthetic dosages based on individual patient 
characteristics, these adjustments cannot always account for 
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variability in patient responses to anaesthesia or changes in 
anaesthetic requirements during the course of surgery [3]. 
In latest years, model-based control has lead to improved 
control loop performance. One of the clearest model based 
technique is Internal Model Control (IMC). IMC has many 
advantages in design control systems. The stability of the 
IMC is only depending on that the controller and nominal 
plant. In addition, even if the IMC system has control input 
saturation, satiability of Internal Model Control is only 
depending on that of the controller and the plant, too. Unlike 
many other developments of modern control theory, IMC 
was widely accepted by control engineering practitioners. It 
is therefore quite natural to attempt to extend IMC concepts 
to various classes of systems. It is thus here that we utilize 
IMC concepts to monitor depth of anaesthesia in order to 
explore the advantages it brings to their control [4]. 
 
A major gain of continuous intravenous drug infusion for 
general anaesthesia is the possibility of keeping something 
like constant value of the effect concentration of the drug in 
use. Alson et al. (2008) presents a method for target control 
infusion for neuromuscular blockade level of patients. The 
estimates of the PK/PD model parameters are computed 
from data collected in the first 10 minutes, after a bolus is 
applied to the patient in the induction phase of anaesthesia 
[5]. Ionescu et al. presents a single-input (propofol) 
single-output (bispectral index, BIS) model of a patient has 
been assumed for prediction as well as for simulation. The 
aim of the controller is to guarantee the model stability in a 
desired range. Absalom et al. produced a closed-loop control 
system of anaesthesia that uses the BIS as the control 
variable to automatically control the target blood 
concentration of propofol Target Controlled Infusion (TCI) 
system. The system was able to provide clinically sufficient 
anaesthesia in all patients, with enhanced accuracy of 
control. There was a tendency for more accurate control in 
those patients in whom the control algorithm incorporated 
effect-site steering [6]. A method and an algorithm are 
proposed for controlling the effect site concentration using a 
TCI method. The method limits the peak plasma 
concentration, thereby slowing the start of anaesthetic drug 
effect but potentially improving side effect. 
A method for an enhanced tuning of the PID controller 
parameters to the patient’s individual dynamics is presented 
by Mendonca & Lago [7]. Auditory evoked potentials (AEP) 
have been reported to accomplish many requirements for 
measurement the level of anaesthesia. The AEP has been 
shown to provide good discrimination of the conversion 
from asleep to aware and vice versa. The development has 
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been made to this system to obtain a single index which 
presents the morphology of the AEP and used this index as 
the input signal for closed-loop anaesthesia during surgery in 
patients who did not receive neuromuscular blocking drugs 
[8]. A robust control of depth of anaesthesia was developed 
by Dumont et al. to design both robust and PID controllers 
based on fractional calculus to control the hypnotic state of 
anaesthesia with intravenous management of propofol. The 
aim of the controllers is to supply an adequate drug 
administration treatment for propofol to evade under or over 
dosing of the patients. The objectives of these controllers are 
considered to compensate for the patients inherent drug 
response variability, to accomplish good output disturbance 
rejection, and to achieve good tracking to set point response 
[9]. 
 
 A synopsis of the pharmacokinetic and pharmacodynamic 
patient’s models used for prediction and for control is given 
in the next section. The depth of anaesthesia control is 
discussed in Section 3. Experiments and results are 
discussed in Section 4, while the conclusion section 
summarizes the main outcome of this strategy. 
 
II. DEPTH OF ANAESTHESIA AND MODELING  
A. Pharmaco-kinetic model  
The human body is assumed to be divided into several 
compartments to drive the PK model [10]. In each 
compartment the drug concentration is homogeneous as 
shown in figure 1. The DoA model considers both propofol 
and remifentanil since this last one has a non-negligible 
effect on the DoA level. 
Hereafter, ce
remi
 (the remifentanil effect concentration) is 
assumed to be given and only the propofol chain is 
considered. The propofol infusion rate “𝑟𝑝𝑟𝑜𝑝 ” is called “𝑢”.   
where 𝑢  is the manipulated variable. This yields the 
continuous linear state space model: 
Fig. 1:  DoA model 
 
 
𝑥1   = 𝐴1𝑥1 + 𝐵1𝑢
𝑐𝑝
𝑝𝑟𝑜𝑝
=              𝐶1𝑥1
                                                    (1) 
With 𝐴1 =  
−𝑘10 − 𝑘12 − 𝑘13
𝑘12
𝑘13
−
𝑘21
𝑘21
0
𝑘31
0
−𝑘31
 , 𝐵1 =
 
104
3600
0
0
 , and 𝐶1 =  
1
1000 ×𝑣1
0 0  
v1 is measured with weight of the patient and coefficient vc 
[L/kg] which represents the volume of compartment one per 
patient unit weight [kg]: 
 
B. Pharmaco-dynamic model 
A PD model presented as a low-pass filter is used to relate 
the propofol plasma concentration 𝑐𝑝
𝑝𝑟𝑜𝑝
 and the propofol 
effect concentration 𝑐𝑒
𝑝𝑟𝑜𝑝
. This yields the following state 
space representation:  
 
 
 
𝑥2   = 𝐴2𝑥2 + 𝐵2𝑐𝑝
𝑝𝑟𝑜𝑝
𝑐𝑒
𝑝𝑟𝑜𝑝
=              𝐶2𝑥2
                                                     (2)     
 
where A2 = -Ke0, B2=Ke0 and C2 = 1. 
 
The effect-site concentration is related to DoA as  (Hill 
equation) [11]: 
 
𝐸(𝑡) = 𝐸𝑜 − 𝐸𝑚𝑎𝑥
𝐶𝑒
𝛾
𝐸𝐶50
𝛾
+𝐶𝑒
𝛾                                           (3) 
 
where 𝐶𝑒 is: 
 
𝐶𝑒 𝑠 =  
𝑘𝑒0
𝑠+𝑘𝑒0
𝐶𝑝(𝑠)                                                             (4) 
 
where  𝑘𝑒0 is the inverse of the effect-site compartment time 
constant and EC50 is the half-maximal effective 
concentration.  
A very important advantage of continuous drug infusion 
for general anaesthesia is the opportunity of keeping nearly 
constant rate of the effect concentration of the drug in use. 
The advances of the pharmacologic and the amount to the 
improvement of adequate drugs, plus the technological 
circumstances such as computer control devices (controlled 
syringes); automatic drug management in the proper doses 
require knowledge of the corresponding PK/PD models. 
There are two corresponding ways to implement the control 
strategy. 
 
 Closed-loop control of drug dosage. 
 Open-loop control. 
Close-loop control of anaesthesia has been a goal of  
many researchers, so closed-loop control has the main 
  
 
advantage of rendering the control action not sensitive to 
model uncertainty [12]. Open-loop control is a type of dual 
feedback, allows a response rapid to the required value [13]. 
On the other hand, system errors will propagate without 
decrease to the tracking error.  From a clinical point of view, 
a perfect controller would lead the induction of anaesthesia 
in order to achieve the goal as fast as possible without initial 
overshoot. After that, the controller would simply keep up 
the desired target as well as possible. For that reason, the 
Internal Model Control (IMC) plays an important role in this 
area. 
III. DEPTH OF ANAESTHESIA CONTROL 
 
A. The Internal Model Control  
The IMC is one such technique that is extensively used in 
chemical and process industries where uncertain models are 
quite common [14]. Internal model control relies on the 
internal model principle, which states that a plant or a 
process can be controlled only if the control system 
incorporates or encapsulates, either implicitly or explicitly, 
some representation of the process [15]. For example in an 
open loop control, the model of the process to be controlled 
is almost exactly known. Hence an inverse model is used for 
the controlling the plant in this case. However, an exact 
model of the plant is not known in almost all practical cases 
and process-model mismatch is very common. These 
uncertainties and un-modeled dynamics in the system 
usually affect system performance. In such cases Internal 
Model Control (IMC) is found to be very useful. The general 
structure of an internal model control methodology 
compared to the classical controller structure like PID. It is 
noted that the system model is explicitly used in the IMC 
structure unlike the classical controller structure [16]. 
 
The disadvantage of the linear IMC controller is that it 
cannot handle open-loop unstable systems and nonlinear 
models should be linearized for designing the controller. 
 
𝐺𝑐(𝑠) is the controller; it is used to control the process, 
𝐺𝑝(𝑠). Assume 𝐺𝑝 (𝑠) is a model of 𝐺𝑝(𝑠). The inverse of 
the model of the process is equal 𝐺𝑐(𝑠), 
 
 𝐺𝑐 𝑠 = 𝐺𝑝 (𝑠)
−1                                                                (5) 
And if 𝐺𝑝 𝑠 = 𝐺𝑝 (𝑠), that is mean the model is an 
exact representation of the process. Then it is obvious that 
the setpoint and the output will always be equal. It is clear 
that this ideal control performance is accomplished in open 
loop without feedback. That is mean we have complete 
knowledge about the process under control with perfect 
achievement control. Also that mean, the feedback control is 
necessary only when information about the process is 
incomplete and imprecise. The process-model mismatch is 
common; that is mean invertible of the process model may 
not be easy and the system is often affected by noises and 
unknown disturbances. Thus the open-loop control will not 
be able to keep output at setpoint. However, it forms the 
basis for the improvement of a control strategy that has the 
potential to accomplish ideal control. This method, IMC has 
the general structure shown in Figure 2. The disturbance 
affecting the system is D(s) in Figure 2. The planning input 
U(s) is introduced to together the model and the process 
[17]. The difference between the process output, Y(s), and 
with the output of the model is the signal 𝐷 (𝑠). The  𝐷 (𝑠) 
can be found as: 
 
 
Fig. 2: Block diagram of the IMC 
 
 
𝐷  𝑠 =  𝐺𝑝 𝑠 − 𝐺𝑝  𝑠  𝑈 𝑠 + 𝐷(𝑠)                          (6) 
 
From equation 6, if D(s) is equal zero, then 𝐷  𝑠  is 
measure of the difference in behaviour between the process 
and its model. Also if 𝐺𝑝 𝑠 = 𝐺𝑝  𝑠 , that mean 𝐺𝑝 𝑠  is 
equal to the unknown disturbance or noise. As a result 𝐷 (𝑠) 
regarded as the information that is missing in the 
model,  𝐺𝑝 𝑠 , and can be used to improve control. The 
control signal can write by, 
 
𝑈 𝑠 =  𝑅(𝑠) − 𝐷(𝑠)  𝐺𝑐 𝑠 
=  𝑅 𝑠 −  𝐺𝑝 𝑠 − 𝐺𝑝  𝑠  𝑈 𝑠 
− 𝐷(𝑠)  𝐺𝑐 𝑠  
                                                                                  (7) 
 
Because 𝑌 𝑠 = 𝐺𝑝 𝑠 𝑈 𝑠 + 𝐷(𝑠)then the closed loop 
transfer function for IMC is equal to: 
 
𝑌 𝑠 =
 𝑅 𝑠 −𝐷 𝑠   𝐺𝑐 𝑠 𝐺𝑝 (𝑠)
1+ 𝐺𝑝  𝑠 −𝐺𝑝  𝑠  𝐺𝑐(𝑠)
+ 𝐷(𝑠)                               (8) 
 
Form the equation 8, we can see that if  𝐺𝑐 𝑠 =
𝐺𝑝 (𝑠)
−1 , and if  𝐺𝑝 𝑠 = 𝐺𝑝  𝑠 , that is mean perfect 
setpoint tracking and disturbance rejection is accomplished. 
Also can notice that, theoretically, if  𝐺𝑝 𝑠 ≠ 𝐺𝑝  𝑠 , 
perfect disturbance rejection can be still be realised 
  
 
provided  𝐺𝑐 𝑠 = 𝐺𝑝 (𝑠)
−1 . Furthermore, to advance 
robustness, the process model mismatch and its effects 
should be minimised. Because a distinct difference and 
failure to match between process and model performance 
usually occur at that the high frequency end of the system’s 
frequency response, a low pass filter  𝐺𝑓 𝑠  is usually added 
to attenuate the effects of process and model discrepancies 
[18]. As a result, the internal model controller is usually 
designed as the inverse of the process model in series with a 
low-pass filter.  The structure of the IMC in DoA is depicted 
in Figure 3. The blocks PK and PD together with the 
nonlinear equation represent the patient’s pharmacokinetics 
and pharmacodynamics, respectively.  Both PK and PD are 
single-input single-output linear time invariant systems. The 
equivalent parallel models for the pharmacokinetics and 
pharmacodynamics are respectively 𝑃𝐾  and 𝑃𝐷  together 
with linearization constant K.  
 
Where 𝐾 = − 𝐵𝐼𝑆0𝛾
4𝐸𝐶50
=−24.16 
Fig. 3: IMC in DoA 
IV. EXPERIMENTS AND RESULTS 
 
This section provides the application and evaluation of the 
IMC control strategy, and also compares their performances 
with the PID controller.  
The data from Hospitals is recorded into a Matlab 
spreadsheet. In case of hardcopy form, the data is manually 
entered on the Matlab spreadsheet. These data are collected 
and analyzed to establish the relative importance of each 
independent variable in the prediction. The data analysis 
results are integrated for model development. The model are 
developed and designed based on these data analysis and 
initial results presented. Then simulations are carried out to 
study the feasibility and reliability. Testing is scheduled to 
the final stage of model development. The implementation 
arrangements will be specified and user’s feedback will be 
incorporated to finalize the model. In this study, however, a 
the IMC used to generate and provides a much easier 
framework for design of robust control systems. 
 
Simulink model is developed for DoA. The nonlinear 
DoA model as shown in the block diagram in Figure 4. To 
perform these actions, Matlab program is developed to 
compute parameters for both linear and nonlinear Simulink 
models. We also compare data from our simulation with real 
data from patients file. The Matlab programs is developed to 
evaluate the influence of several parameters (𝛶, 𝐾𝑒𝑜 , and   
𝒄𝒆
𝒑𝒓𝒐𝒑
  ) on the nonlinear model. The simulations evaluate 
the influence of drugs in steady state on the Hill equation. 
The BIS and the infusion rate in typical cases of automatic 
control are shown. 
Figure 5 shows the closed loop simulation for controlled 
output (BIS) for the IMC. The controller performance over 
the family of the patients is affected due to inter-patient 
variability, when using a nominal model for IMC strategy. 
Notice that the IMC strategy includes an identification of the 
patient specific parameters, and therefore, it takes into 
account the patient variability to obtain a better control 
performance. 
During the induction phase, the time-to-target for the IMC 
strategy has rather high performance. The IMC controller 
brings the BIS variable to the reference interval. The results 
in this study can be attributed to the fact that the IMC 
controller is more cautious controller, making an exchange 
between small time-to-target, small undershoot and 
robustness against patient variability as shown in figure 6.      
    
Fig. 4: Non linear DoA model built in Simulink 
 
Fig. 5: Simulink diagram for IMC system 
 
 The closed loop performance of the IMC will be present 
here. Because plasma propofol concentration measurement 
is unavailable, it is estimated through the nominal PK model. 
BIS is measured online. The controller has maintained BIS 
between 40 and 60 during the surgery. Firstly, it is assumed 
that the patient is in a fully awake state (BIS≈100) and then 
1
240s+1
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  y = Cx + Du
PK Model1
x' = Ax + Bu
  y = Cx + Du
PK Model
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s+ke0
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the controller is turned on the set-point is changed from 100 
to 50.  This condition brings the patient to the surgical 
operating range (40 ≤ BIS ≤60) which must be maintained for 
the period of the surgery.  The predicted plasma propofol 
concentration must be among 1 μg/mL and 5 μg/mL. The lower 
bound guarantees a lowest amount delivery of anaesthetic, 
whereas the upper bound prevents overdosing of the drug for an 
average subject. The manipulated variable (propofol infusion 
rate) u is constrained between 0 and 40 mg/kg/h. The higher 
bound is needed because higher propofol infusion leads to more 
rapidly increase of propofol concentration in the subject’s body 
and this may lead to hypnotic crisis, cardiac arrhythmia, or even 
cardiac arrest. The lowest amount bound on u reflects the 
impossibility of administering negative concentrations of 
propofol. 
 We start on by discussing the design of IMC. Because the 
safe regulation of DoA level is very crucial during the surgery, 
the constraints imposed on the inputs will be hard constraints, 
that is, at any time the controller should not violate these limits. 
The modification parameters for the IMC controller are the 
filter time constant λ which is put at 1.7 and order of the filter n 
which is set at 2. Here also, the value of K used is -24.16. With 
the PID controller, the settings were 𝐾𝑐 =  −0.0598, 𝜏𝐼 =
 28.476, and 𝜏𝐷  =  2.368. 
 
Fig.6. Performance of the IMC 
 
The comparison of closed-loop performance of the two 
controllers is discussed next. The response is faster with PID 
controller than with the IMC controller, a small offset 
persists throughout the simulation time. Figure 8 shows the 
predicted plasma propofol concentration, where it is seen 
that all the controllers result in overshoot (higher with PID 
controller) but are still maintained within the constraints.  
 
  We would like to test if the two controllers are able to meet 
performance specifications despite significant and reasonable 
variation in the model parameters (inter- and intra-patient 
variability) as shown in table 1. At this point, we assume that 
variability is in both the PK and PD (based on patient’s 
sensitivity to the drug) model parameters. Our control 
simulations showed that the variability in PD parameters 
have more impact on BIS than the variability in PK 
parameters. First, each PK parameter (k10 , k12 , k21 , k13 ,
k31 , V1, V2, and V3) is assumed to vary over three levels 
(minimum, average, maximum).Simulations showed that 
changes in volumes of the compartments (V1, V2, and V3) 
has very a smaller amount effect on the performance. For the 
insensitive patient, depletion rate constants of the central 
compartment (k10 , k12 , and k13) are high (0.1488, 0.139, 
and 0.05211, respectively) and generating rate constants 
(k21 , k31) are low (0.041, and 0.0021, respectively). In the 
PD parameters, higher EC50 (3.7) indicates the need for 
further drug to get the same DoA level, higher γ (3.12) 
represents higher nonlinearity and lower ke0 (0.2388) 
indicates sluggishness in response. For the sensitive patient 
k10 , k12 , and k13  are low (0.089, 0.084, and 0.031, 
respectively) and k21 , k31 ,  are high (0.0691, and 0.0039, 
respectively). In the PD parameters, lower EC50 (1.6) 
indicates the need of a smaller amount drug to get the same 
DoA level, lower γ (2) represents lower nonlinearity, and 
higher ke0 (0.459) indicates more rapidly response. Also, 
since ke0 represents the process gain, higher ke0 (higher gain) 
represents faster response and lower ke0 (lower gain) 
represents slower response of the process.  
 
TABLE I 
VALUES OF THE PARAMETERS FOR THE 15 PATIENT SETS ARRANGED IN 
THE DECREASING ORDER OF THEIR BIS SENSITIVITY TO PROPOFOL 
INFUSION 
 
Parameter 
Patient no.       k10            k12        k21           k13              k31          ke0         EC50        γ 
1 (sensitive)      0.08925    0.084       0.06875      0.031425    0.004125      0.459      1.6             2 
2                        0.14875    0.14         0.04125      0.052375    0.004125      0.239      1.6             2 
3                        0.14875    0.112       0.04125      0.0419        0.004125      0.239      1.6        3.122 
4                        0.14875    0.14         0.04125      0.052375    0.004125      0.239      1.6        3.122 
5                        0.08925    0.084       0.04125      0.052375    0.002475      0.459      2.65      2.561 
6 0.                    08925       0.084       0.06875      0.031425    0.002475      0.349      2.65      2.561 
7                        0.14875    0.112       0.06875      0.031425    0.002475      0.459      2.65      2.561 
8 (nominal)       0.119        0.112       0.055          0.0419        0.0033          0.349       2.65     2.561 
9                        0.119        0.112       0.055          0.0419        0.0033          0.239       2.65         2 
10                      0.119        0.112       0.055          0.0419        0.0033          0.239       2.65      2.561 
11                      0.08925    0.084       0.06875      0.031425    0.002475      0.459       3.7           2 
12                      0.14875    0.112       0.06875      0.031425    0.002475      0.349       3.7        2.561 
13                      0.08925    0.084       0.06875      0.031425    0.002475      0.239       3.7        2.561 
14                      0.08925    0.084       0.06875      0.031425    0.002475      0.239       3.7        3.122 
15                      0.08925    0.084       0.04125      0.052375    0.002475      0.239       3.7        3.122 
 
 
 
Fig7: PID controller 
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Fig. 8: Performance of PID controller 
 
Fig. 9: Infusion rate of propofol (IMC) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Infusion rate of propofol (PID) 
Fig. 11: Predictive plasma propofol concentration (IMC) 
 
V. CONCLUSIONS 
 
In this study, internal model control, for regulation of 
anaesthesia using BIS as the controlled variable have been 
evaluated thoroughly. The performance of this controller is 
considered along with the performance of the conventional PID 
controller. In comparison with conventional PID controller, the 
advanced, model-based controllers are found to be robust to 
intra- and inter-patient variability, and better at handling 
disturbances and measurement noise. The performance of the 
IMC controller is found to perform the best and hence 
recommended for DoA control. 
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